|
Vaccine Working Group (Filovirus)
|
Committee, Work group, Advisory group, or Task Force
|
FDA, OS
|
NIAID
|
This working group is collaborating on NHP control animal data and meta analysis. Collaboration includes exchange of study data, study reports, development of a NHP control database and statisical analysis plan and report. The objective is to provide a data package to the Food and Drug Administration (FDA) to support vaccine product development and licensure.
|
|
Value Set Authority Center (VSAC)
|
Resource Development
|
AHRQ, CDC, CMS, OS
|
NLM
|
The National Library of Medicine (NLM) provides an online repository of value sets (code sets from standardized medical vocabularies) that are used for clinical quality measurement in the CMS EHR Incentive Program (meaningful use). The Value Set Authority Center (VSAC) provides downloadable access to all official versions of vocabulary value sets contained in the 2014 Clinical Quality Measures (CQMs). Each value set consists of the numerical values (codes) and human-readable names (terms), drawn from standard vocabularies such as SNOMED CT ®, RxNorm, LOINC, and ICD-10-CM, which are used to define clinical concepts used in clinical quality measures (e.g., patients with diabetes, clinical visit).
|
|
Violence Against Women Steering Committee (DHHS VAW)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, HRSA, IHS, OS, SAMHSA
|
OD/DPCPSI/ORWH, NIA, NIAAA, NICHD, NIDA, NIMH, NLM, OD/DPCPSI, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR
|
The DHHS Violence Against Women Act (VAWA) steering committee is chaired by the Office on Women’s Health (OWH). The VAWA committee has the responsibility for coordinating the Department of Health and Human Services (DHHS) response to issues related to violence against women and their children, and also coordinates DHHS violence-related activities with those of other Federal agencies. The members of the committee establish links with professional societies in the health and social service fields to increase attention to women’s health and violence issues. The members of the committee also serve as resource experts for the National Advisory Committee on VAW, which is chaired by the HHS Secretary and the DOJ Attorney General.
|
|
Virology Interest Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIMH, NINDS
|
The Virology Interest Group comprises researchers at NIH and in the local area who are interested in virology. The group organizes activities designed to promote interactions and exchange information.
|
|
Work Group on Harmonizing Hemoglobinopathy Data Sets
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NLM, NCATS, NHLBI, NICHD, NIGMS, OD/OER
|
The mission of the Workgroup for Harmonizing Hemoglobinopathy Data Sets is to create a resource for federal programs and extramural communities to use in data systems that incorporate data elements in hemoglobinopathies. Specifically this entails establishing a Hemoglobinopathies Uniform Medical Language including: identifying specific goals and objectives for the kind of data that are required by these programs; case definitions for electronic data systems at all levels; consensus about conditions and data elements to be included; and differentiation between data needs for surveillance and for registries/biorepository.
|
|
Working Groups to Develop Department of Health and Human Services (HHS) HIV/AIDS Treatment and Prevention Guidelines
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
OD/DPCPSI/OAR, NIAID, NICHD
|
There are five Office of AIDS Research Advisory Council (OARAC) Working Groups to maintain updated federally approved medical practice guidelines for HIV/AIDS Treatment and the Prevention of HIV Transmission from Mother to Infant. The five working groups are the 1) Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents, 2) HHS Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, 3) HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV, 4) HHS Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children, and 5) Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission. The HHS HIV/AIDS Treatment and Prevention Guideline Panels update guidelines for HIV/AIDS care providers with the most current information on combination antiretroviral therapy, treatment and prevention of opportunistic infections for people with HIV; the prevention of HIV transmission from an infected mother to her infant; and the safety and efficacy of HIV/AIDS therapies.
|
|
World Cancer Research Day, HPVAware, and World No Tobacco Day, World Cancer Day
|
Public Education Campaign
|
OS
|
NCI, FIC
|
The National Cancer Institute (NCI) Office of Communications and Public Liaison and Center for Global Health collaborate with the Department of Health and Human Services (DHHS) Assistant Secretary for Public Affairs Digital Media Office to coordinate public education campaigns featuring digital materials that highlight prevention promotion and wellness programs. These materials are shared across all HHS Operating Divisions (OPDIVs).
|
|
World Health Organization (WHO) Programme on Prevention of Deafness and Hearing Loss
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIDCD
|
Stakeholders’ meeting for the WHO Programme on Prevention of Deafness and Hearing Loss to explore mechanisms to offer financial support for a World Report on Hearing (prepared and disseminated through WHO).
|
|
Zika Supplement for Virus Tissue Tropism During Pregnancy
|
Resource Development
|
FDA, HRSA
|
NIAID
|
This activity addressed a time-critical public health crisis to understand Zika virus (ZIKV) and HIV in the Americas. This supplement leverages unique existing collaborations and resources from the parent award to develop models for ZIKV pathogenesis that currently do not exist. The investigators have the ideal expertise in virology, immunology, primate models of pregnancy, and pediatrics to quickly establish a relevant animal model for ZIKV infection of pregnant women. This supplement will perform initial studies of virus replication and pathogenesis in pregnant female macaques and their offspring. This will directly address a rapidly expanding public health emergency in the Americas that may threaten vulnerable HIV+ populations.
|
|
Zoster Working Group of the Centers for Disease Control and Protection (CDC) Advisory Committee for Immunization Practices
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID
|
The Working Group discusses new zoster vaccines and makes recommendations to the Advisory Committee for Immunization Practices (ACIP) on how to use zoster vaccines.
|